BSECompany Update1d ago · 30 Oct 2026, 03:17 pm

Board Meeting Outcome - Conclusion

Sun Pharmaceutical Industries Ltd · 524715

✦ AI SummaryAuditor Change

Sun Pharmaceutical Industries Ltd has announced the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as its new statutory auditors, following the completion of the second consecutive term of the existing auditors, S R B C & CO LLP.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sun Pharmaceutical Industries Ltd - 524715 - Appointment Of Statutory Auditors Pursuant To Mandatory Auditor Rotation

Attachments (1)

📄

8c1e7a04-f30c-4229-8189-88b576aab720.pdf

pdf

Download →
View document text
Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 30 October 2026 National Stock Exchange of India Limited BSE Limited NSE Code: SUNPHARMA BSE Code: 524715 Outcome of the Board Meeting held today, i.e., 30 October 2026 - Conclusion Further to our earlier intimation made today, 30 October 2026, this is to further inform that the Board of Directors of the Company, at its meeting held today, has, inter alia, approved the following: Appointment of Statutory Auditors Pursuant to Mandatory Auditor Rotation S R B C & CO LLP, Chartered Accountants (“SRBC”), the existing Statutory Auditors of the Company, shall complete its second consecutive term of five years at the conclusion of the Annual General Meeting (“AGM”) of the Company for the financial year 2026-27. Accordingly, SRBC shall cease to hold office as the Statutory Auditors of the Company upon completion of its tenure, in accordance with the mandatory auditor rotation requirements prescribed under Section 139(2) of the Companies Act, 2013. Based on the recommendation of the Audit Committee and subject to the approval of the shareholders of the Company, the Board has approved the appointment of Deloitte Haskins & Sells Chartered Accountants LLP (Firm Registration No. 117364W/W100739) as the Statutory Auditors of the Company for a term of five consecutive years, commencing from the conclusion of the AGM of the Company for the financial year 2026-27 and continuing until the conclusion of the AGM of the Company for the financial year 2031- The disclosures required pursuant to Regulation 30 of the Listing Regulations, read with the applicable SEBI circulars, are enclosed herewith as Annexure A. The Board Meeting commenced at 10:45 AM (IST), was adjourned for a break, subsequently resumed, and concluded at 02:55 PM (IST). For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 Annexure A Disclosure pursuant to Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Particulars Details 1 Name Deloitte Haskins & Sells Chartered Accountants LLP, Firm Registration No. 117364W/W100739 2 Reason for change viz. appointment Appointment as the Statutory Auditors of the Company consequent upon completion of the second consecutive term of the existing Statutory Auditors, S R B C & CO LLP, at the conclusion of the Annual General Meeting of the Company for the financial year 2026-27, in accordance with Section 139(2) of the Companies Act, 2013. 3 Effective date of appointment From the conclusion of the Annual General Meeting of the Company for the financial year 2026-27, subject to the approval of the shareholders. 4 Term of appointment Five consecutive years, commencing from the conclusion of the Annual General Meeting of the Company for the financial year 2026-27 and continuing until the conclusion of the Annual General Meeting of the Company for the financial year 2031-32, subject to the approval of the shareholders. 5 Brief profile Deloitte Haskins & Sells Chartered Accountants LLP (Firm Registration No. 117364W/W100739) is a firm of Chartered Accountants registered with the Institute of Chartered Accountants of India (“ICAI”) and is part of the Deloitte network of professional services firms. The firm has extensive experience in providing audit and assurance services to large listed and multinational companies across various sectors, including pharmaceuticals, life sciences and healthcare. The firm has significant experience in auditing leading companies in the pharmaceutical and healthcare sectors and is supported by a multidisciplinary team of audit, tax, technology and industry specialists. 6 Disclosure of relationships between Not applicable. directors Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives